Assembly Biosciences(us:ASMB)

    15.21

    -3.80%

    Updated on 2024-12-22

    Open:15.70
    Close:15.21
    High:16.26
    Low:15.00
    Pre Close:15.81
    Volume:30655.00
    Amount:478060.19
    Turnover:0.48%
    Shares:6.36M
    MarketCap:96.68M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3029117525618.52%5107
    2024-03-314464728311.81%01029
    2023-12-31497206331.10%17713
    2023-09-303539034907.42%2314
    2023-06-30401046539319.95%3418
    2023-03-31431204362723.18%3920
    2022-12-31521419377829.03%21032
    2022-09-30591659604234.23%41031
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Vanguard Group Inc1963683.58%14520.74%
    2024-03-31Millennium Management Llc1249222.28%40893.38%
    2024-03-31Blackrock Inc.779611.42%-1035-1.31%
    2024-03-31Geode Capital Management, Llc521970.95%11992.35%
    2024-03-31Acuitas Investments, Llc497320.91%27601124.72%
    2024-03-31Renaissance Technologies Llc394600.72%35859.99%
    2024-03-31Federated Hermes, Inc.253940.46%0
    2024-03-31Bridgeway Capital Management, Llc145000.26%10.01%
    2024-03-31State Street Corp121090.22%-2-0.02%
    2024-03-31Fmr Llc113180.21%-43-0.38%

    About

    Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
    Address:Two Tower Place,7th floor

    Market Movers